We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
94 hedge funds and large institutions have $75.9M invested in Invesco Pharmaceuticals ETF in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
267% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 6
24% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 21
16% more funds holding
Funds holding: 81 → 94 (+13)
10% more capital invested
Capital invested by funds: $69.1M → $75.9M (+$6.72M)
0.18% more ownership
Funds ownership: 22.92% → 23.1% (+0.18%)
Holders
94
Holders Change
+13
Holders Change %
+16.05%
% of All Funds
1.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
26
Reduced
21
Closed
6
Calls
$377K
Puts
–
Net Calls
+$377K
Net Calls Change
+$156K
Top Buyers
Top Sellers
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$8.29M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.41M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$955K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$435K |
| 5 |
Goldman Sachs
New York
|
-$321K |
